Professional Perspectives on PN Among Registered Dietitians in Saudi Arabia: A Mixed-Methods Assessment
The study surveyed 88 registered dietitians in Saudi Arabia to assess attitudes and readiness for personalized nutrition (PN) and multi‑omics technologies. Adoption of PN technologies was low at 16%, with work experience showing a modest positive correlation to perceived usefulness, while formal education did not. Strong correlations were found between perceived usefulness and interest in genomics, metabolomics and microbiome testing. Qualitative analysis highlighted knowledge gaps, cost and infrastructure as primary barriers and identified education, policy support and tech integration as key facilitators.
Clinical Implications of Malnutrition in Huntington's Disease Progression: Evidence From a Chinese Cohort and Mendelian Randomization
Researchers evaluated nutritional status in 113 Chinese Huntington’s disease patients using CONUT, GNRI, and PNI scores and compared them with matched healthy controls. Malnutrition was markedly more common in HD, especially by CONUT (34.5% vs 13.3%) and GNRI (8% vs...
Powering the Next Wave of Cell Therapy: From iPSC-Derived Cells to In Vivo Reprogramming
Induced pluripotent stem cells (iPSCs) are being engineered into diverse therapeutic cell types, while in vivo reprogramming aims to convert resident cells directly within patients, eliminating traditional cell‑manufacturing steps. Both strategies depend on precise recombinant growth factors, cytokines, extracellular matrix proteins...
Reinforced Biotubes: Readily Available Regenerative Vascular Grafts
Researchers Cheng, Zhi and Midgley have unveiled reinforced biotubes—bioengineered vascular grafts that combine living cells with nanofibrous reinforcement—to address durability and availability limits of current grafts. The tubes are fabricated in bioreactors, seeded with smooth‑muscle and endothelial progenitor cells, and...
Gene Therapies for Hearing Loss Strike an Encouraging Note in Embattled Modality
Gene‑therapy candidates for hereditary hearing loss are gaining traction as safety concerns ease with localized delivery. Regeneron’s DB‑OTO and Eli Lilly’s AK‑OTOF have each demonstrated clinically meaningful hearing improvements in early‑stage trials, positioning them as frontrunners for the first approved deafness...
Bayada Nonprofit Executive Director On The At-Home Care Medicaid Squeeze, Industry Consolidation
Sue Chapman Moss, Bayada’s senior vice president of payer strategy and new executive director of Hearts for Home Care, warned that state Medicaid reimbursement is tightening after the One Big Beautiful Bill, pressuring home‑based providers with lower rates and reduced...
Are There Disadvantages of Knee Replacement Surgery?
Knee replacement remains one of the most common orthopaedic procedures, with roughly 800,000 surgeries performed annually in the United States. Advances such as cementless implants, robotics and refined soft‑tissue balancing have improved precision and reduced recovery time, making about half...
Chinese Surgery Robot Outperforms Humans, Cuts Brain Imaging Time by 29%
Chinese researchers unveiled the YDHB‑NS01 cerebrovascular intervention robot, which cuts brain angiography time by roughly 29%, shaving nine minutes off a standard 38‑minute procedure. In a head‑to‑head trial at Peking Union Medical College Hospital, the robot matched manual methods with...
Elpida Launches AI-Powered Marketing Compliance Platform for Healthcare Brands
Elpida, an AI‑driven marketing compliance platform for healthcare, launched today to address the growing friction of manual content reviews. The FDA’s new generative‑AI enforcement tool has spiked warning letters by 73%, highlighting the urgency for automated safeguards. Elpida’s "Live Regulatory...
9 Months In, FDA’s New Priority Voucher Program Still Clouded With Uncertainty
The FDA’s National Priority Voucher (CNPV) program, launched in June 2025, promises to cut drug review times from 10‑12 months to just one or two months for products that meet defined national priorities. Early successes include Johnson & Johnson’s Tecvayli/Darzalex...
Remedy Place Launches a ‘Smart NAD Injection Pen’ — and ‘Smart Peptide Pens’ Could Be Next
Remedy Place, a boutique wellness club with locations in Los Angeles, New York and Boston, has introduced a $500 smart NAD injection pen that lasts 30 days and is reusable with a fresh needle for each dose. The pen is manufactured by UK‑based...
Scientists Discover Surprising Brain Trigger Behind High Blood Pressure
University of Auckland researchers have identified the lateral parafacial region of the brainstem as a hidden driver of neurogenic hypertension, linking forced exhalations to sympathetic nerve activation. In animal models, silencing this nucleus normalized blood pressure, confirming a causal link...
Scotland Becomes First in UK to Test Newborns for Rare Genetic Condition
Scotland has become the first UK nation to add spinal muscular atrophy (SMA) to its universal newborn heel‑prick screening, rolling it out to all babies as part of a two‑year pilot. The program will test roughly 50,000 infants annually, identifying...
Malaysia to Join WHO Pandemic Preparedness Talks Virtually Amid Middle East Conflict
Malaysia’s Health Ministry, together with the Attorney‑General’s Chambers and other agencies, will represent the country at the sixth Intergovernmental Working Group (IGWG6) negotiations on pandemic preparedness, held March 23‑28 at WHO headquarters in Geneva. The delegation will participate virtually, a decision...
Wondering if You Really Need that Dental Treatment? Here’s What to Ask and How to Get a Second Opinion
Dental costs deter roughly 30% of Australian adults and nearly half of New Zealanders from seeking care, prompting many to question recommended restorations. Fillings, crowns and implants each have distinct longevity—5‑15 years for composites, 10‑15 years for crowns, and decades for implants with...
NADPH Oxidase-1 Suppression Prolongs the Antidepressant-Like Effect of Ketamine
Researchers introduced K‑4, a novel AMPA‑receptor positive allosteric modulator, which produced rapid and sustained antidepressant‑like effects in treatment‑resistant depression rat models. Bulk RNA‑seq revealed that K‑4 markedly down‑regulated NADPH oxidase‑1 (NOX‑1) in the medial prefrontal cortex and lateral habenula. Pharmacological...
The Human Cost of Unsafe Abortions
Romania’s 1966 Decree 770 sharply restricted abortions, causing births to double and maternal mortality to surge by nearly 150 % over the next two decades. Illegal, unsafe procedures accounted for more than 80 % of those deaths, with an estimated 10,000 women dying...
Insight: Mar 24
Australian lawmakers in Queensland and the Northern Territory have moved to prohibit public‑system doctors from prescribing gender‑affirming medication to new trans patients under 18, while allowing those already in care to continue treatment. The changes arrive amid a global reassessment...
People with Cannabis Disorder Do Not Seem to Pay Increased Attention to Pictures of Cannabis
Australian researchers examined whether people with moderate‑to‑severe cannabis use disorder (CUD) display an attentional bias toward cannabis images. Using a visual‑probe task with 108 participants, they found no overall bias compared with controls. Within the CUD group, only a marginally...
A GI Doctor Says You’re Probably Ignoring This Bathroom Red Flag
Harvard gastroenterologist Dr. Trisha Pasricha explained that normal bowel habits can vary widely, with frequency ranging from once daily to once every three days depending on diet, fiber, and lifestyle. She warned that spending more than five minutes on the...
FDA Drug Safety Communication: Revised Recommendations for Celexa (Citalopram Hydrobromide) Related to a Potential Risk of Abnormal Heart Rhythms with...
The FDA issued a Drug Safety Communication clarifying that citalopram (Celexa) should not be prescribed above 40 mg daily because higher doses significantly prolong the QT interval and can trigger fatal Torsade de Pointes. The label now mandates a maximum of...
FDA Drug Safety Communication: Updated Information About the Risk of Blood Clots in Women Taking Birth Control Pills Containing Drospirenone
The FDA has updated labels for drospirenone‑containing oral contraceptives after reviewing epidemiologic studies that suggest a potentially higher risk of venous thromboembolism compared with other progestins. The new warnings note that some studies report up to a three‑fold increase in...
FDA Drug Safety Communication: New Warning and Contraindication for Blood Pressure Medicines Containing Aliskiren (Tekturna)
The FDA issued a drug safety communication on April 20, 2012, adding a contraindication for aliskiren‑containing antihypertensives when combined with ACE inhibitors or ARBs in patients with diabetes, and a warning for those with moderate to severe renal impairment. The...
FDA Drug Safety Communication: Updated Information on Drug Interactions Between Victrelis (Boceprevir) and Certain Boosted HIV Protease Inhibitor Drugs
The FDA issued an updated Drug Safety Communication warning that co‑administration of Victrelis (boceprevir) with ritonavir‑boosted HIV protease inhibitors—atazanavir, darunavir, or lopinavir/ritonavir—is not recommended for patients co‑infected with hepatitis C and HIV. The interaction lowers blood concentrations of both drugs,...
FDA Drug Safety Communication: Safety Review Update of Cancer Drug Revlimid (Lenalidomide) and Risk of Developing New Types of Malignancies
The FDA added a safety warning to Revlimid (lenalidomide) after clinical trials showed a markedly higher incidence of second primary malignancies in newly diagnosed multiple myeloma patients. Pooled data revealed a three‑fold increase (7.9% vs 2.8%) in cancers such as...
The Saga of Utah’s Rx Refill Bot: A Bold Bet on AI & Researchers Who Cried Foul
Utah became the first state to allow an AI system to autonomously handle routine prescription refills for patients with chronic conditions. The pilot, run with New York‑based startup Doctronic, seeks to reduce delays and improve medication adherence. A London‑based security firm,...
Calif. Ambulance Service Marks 50 Years of EMS Service
Bi‑County Ambulance marked its 50th anniversary serving Yuba and Sutter counties, honoring founder Kelly Bumpus and highlighting its evolution from a small local operation to a regional EMS leader. President Alex Bumpus announced recent facility upgrades and advanced training tools...
FDA Drug Safety Communication: Cefepime and Risk of Seizure in Patients Not Receiving Dosage Adjustments for Kidney Impairment
The FDA issued a Drug Safety Communication reminding clinicians to adjust cefepime doses for patients with creatinine clearance ≤ 60 mL/min. Non‑convulsive status epilepticus has been linked to inappropriate dosing, with 59 reported cases since 1996, 58 of which involved renal dysfunction...
FDA Drug Safety Communication: Seizure Risk for Multiple Sclerosis Patients Who Take Ampyra (Dalfampridine)
The FDA issued a Drug Safety Communication warning that dalfampridine (Ampyra), approved to improve walking in multiple sclerosis patients, carries a significant seizure risk, especially shortly after therapy initiation. Post‑marketing data show most seizures occur within days‑to‑weeks and in patients...
Predictors and Diagnostic Threshold Values of Functional Dependency in Individuals Aged 80 and Over: A Retrospective Cross-Sectional Study
A retrospective cross‑sectional study of 444 Balıkesir residents aged 80 and over found that 70.27% were functionally dependent according to the Katz ADL scale. Multivariable analysis identified older age, higher depressive scores, elevated BMI, lower MMSE and MNA‑LF scores as...
FDA Drug Safety Communication: FDA Recommends Against Use of Revatio (Sildenafil) in Children with Pulmonary Hypertension
The FDA issued a drug safety communication recommending that Revatio (sildenafil) not be prescribed to children aged 1‑17 for pulmonary arterial hypertension. A long‑term pediatric trial of 234 patients showed no exercise benefit and a three‑fold increase in mortality at...
Integrated Psychological Treatment Improves Outcomes in Dual Disorders
A new international consensus study published in the Journal of Clinical Medicine finds integrated psychological treatment for dual disorders outperforms separate treatment. Researchers from the University of Barcelona, CEU Cardenal Herrera, Bellvitge University Hospital and European University of Madrid reviewed...
NYU Stern Report Urges Regulation of Private Equity in Healthcare
A new NYU Stern Center for Business and Human Rights report warns that private‑equity ownership of healthcare facilities has driven higher complication rates, staffing cuts, and a tenfold increase in bankruptcy risk, prompting calls for regulation. The study finds PE...
Genetic Study Finds Links Between Height and Risk of Cardiovascular and Reproductive Conditions in East Asian People
A large‑scale GWAS of over 120,000 Han Taiwanese participants identified 293 genetic variants linked to height and five linked to familial short stature. The study found that greater genetically‑predicted height raises the risk of atrial fibrillation and endometriosis in East...
Health Insurance Jargon Can Be Frustrating and Confusing. Here's How to Navigate It
After the Affordable Care Act subsidies expired at the end of 2025, U.S. consumers face higher premiums and a maze of health‑insurance jargon. The article breaks down core terms—premium, deductible, coinsurance, copayment, and out‑of‑pocket maximum—explaining how each affects annual costs....
Chronic Jaw Pain and Dental Issues: Full Mouth Reconstruction
Chronic jaw pain often stems from dental problems such as malocclusion, missing teeth, or worn restorations, rather than solely stress or muscle tension. Dental practices like Sunny Isles Dental conduct comprehensive evaluations to pinpoint these underlying causes and recommend full...
A Once in a Generation Opportunity to Reimagine Rural Health
Rural America faces chronic workforce and infrastructure challenges, but the CMS Rural Health Transformation Program (RHTP) offers a multi‑year funding initiative to modernize care delivery. The program encourages a shift toward community‑centered, data‑driven population health models that integrate clinical services...
Performant Isn't a Word
A forum post titled “Performant isn’t a word” critiques the branding language used by Performant Healthcare, a U.S. provider of payment‑integrity solutions. The author highlights that the term “performant” is uncommon and may confuse stakeholders. The post also links to...
Could Ozempic Help People Whose Cancer Has Spread to the Brain?
A large retrospective analysis of over 19,000 patients with cancer, type 2 diabetes and brain metastases found that those prescribed GLP‑1 receptor agonists such as Ozempic or Wegovy experienced a 37% reduction in three‑year mortality compared with matched controls. The survival...
Pa. Officials Back EMS Funding Push for Wyoming County Ambulance Services
Factoryville Borough Council endorsed a $500,000 federal Community Project Funding grant to bolster emergency medical services across Wyoming County. The council also praised Tunkhannock Community Ambulance, now the borough’s primary EMS provider after the fire company stopped ambulance operations. Officials...
These Activities Show Promise For Those Suffering From Dementia
A review of 98 studies published in *Aging & Mental Health* finds that mind‑body interventions (MBIs) such as yoga, tai chi, and music therapy can improve mental health for people with dementia. The benefits are strongest when sessions last under...
Woman, 45, Took Birth Control Shots for 21 Years. Now, She’s Been Diagnosed with 4 Brain Tumors
A 45‑year‑old woman who received hormonal birth‑control injections for 21 years was diagnosed with four benign meningiomas, prompting doctors to advise discontinuing the shots. The tumors, the largest measuring 1.4 inches behind her right eye, were discovered after she reported ear pulsations...
Total Thoracoscopic Vs. Small-Incision Surgery: Rib Fracture Study
A new comparative clinical study evaluated total thoracoscopic surgery against thoracoscopy‑assisted small‑incision surgery for multiple rib fractures. The total thoracoscopic approach yielded significantly lower intra‑operative blood loss, reduced postoperative pain, and shorter hospital stays, although it required slightly longer operative...
LEGO MRI Sets Are Helping Reduce Anxiety for Children in Hospitals
LEGO’s Social Responsibility team has donated more than 10,000 LEGO MRI scanner models to over 100 hospitals worldwide, helping more than one million children prepare for MRI scans. The kits, accompanied by staff training videos, let kids explore a replica...
Kyoto Medical Firm to Launch Personal iPS Cell Storage Service
Kyoto-based iPS Portal Inc. will launch a personal induced pluripotent stem cell storage service in April, allowing individuals to generate iPS cells from their own blood for future clinical use. The service, developed with pharmaceutical experts, will cost between 10 million...
UK Study Reveals No Additional Advantage of Surfactant Therapy in Severe Bronchiolitis Cases in Infants
UK researchers completed the largest randomized trial evaluating exogenous surfactant in infants with severe bronchiolitis requiring mechanical ventilation. The Bronchiolitis Endotracheal Surfactant Study (BESS) enrolled 232 infants across 15 pediatric centers and found that surfactant administration did not shorten ventilation...
Psychedelic Drug MDMA Could Help Treat PTSD—But There's a Reason It's Not Widely Available
Australia became the first nation to reclassify MDMA from a prohibited to a controlled substance, permitting its use in PTSD treatment under strict conditions. The 2026 guidelines limit MDMA‑assisted psychotherapy to adults who have not responded to first‑line therapies, require...
High Ambient Temperatures Linked to CKD Prevalence, ESKD Incidence
A new study links higher ambient temperatures to greater chronic kidney disease (CKD) prevalence and end‑stage kidney disease (ESKD) incidence across U.S. counties. Researchers found that each 1 °C increase in annual average temperature raises diagnosed CKD prevalence by 0.23 percentage...
Prothena Partners Present Data Supporting Next Generation Treatments for Parkinson’s and Alzheimer’s Disease at AD/PD™ 2026
Prothena and its partners presented new clinical data on prasinezumab for Parkinson’s disease and BMS‑986446 for Alzheimer’s disease at the AD/PD 2026 conference in Copenhagen. The PASADENA and PADOVA extensions suggest a two‑year disease‑progression delay and sustained biomarker effects, supporting the...